Chemical and Biological Medical Treatment Symposium V (CBMTS V)
Venue: Spiez Laboratory
|Event Date/Time: Apr 25, 2004||End Date/Time: Apr 30, 2004|
|Registration Date: Apr 18, 2004|
|Early Registration Date: Feb 25, 2004|
|Abstract Submission Date: Feb 29, 2004|
|Paper Submission Date: Apr 01, 2004|
Who Should Attend?
Industry, government and academic professionals with an interest in the chemical, biological, and radiological threat, whether the threat is from war, terrorist actions or accidents and incidents, natural or man-made. Medical, public health and medical research professionals, including primary care physicians, practitioners and veterinarians; Local, regional and national laboratory representatives; firstresponders and HAZMAT specialists, including emergency, crisis management and mitigation, and civil defense personnel; industry scientists and engineers; and specialists in computer risk modeling and planning, training and local community interface.
D. Call for papers/topic and theme areas
Papers could cover any one or a combination of the listed topic areas and sub-areas as well as areas not listed. For ‘non-listed’ areas, the author should show how the subject does fit with the theme of the CBMTS V. Please consider the theoretical as well as the practical and the scientific and operational in problem definition, preparation and response. The importance of local, national, regional, and international preparation and response will be of the highest interest to all professionals attending the CBMTS V.
The following listed major topic, sub-topic areas will be further updated and changed per participants’ requests and at planned meetings of the CBMTS Planning Group at the Spiez Laboratory in Spiez, Switzerland.
(Important Note: CBMTS V will be held under the CBMTS rules that state all participants will present a Science Review Committee approved paper either from the podium or from a poster. Additionally, the CBMTS V Symposium has a physical limit of approximately 130 participants maximum and this will also limit the number of Papers that may be accepted.)
E. The proposed topic areas (and sub-areas are the guide for the proposed papers):
1. CBR Agents: characterization and mode of action
2. Analysis: identification, quantitation of substances; threat assessment; rapid differentiation between biological, toxin and chemical incidents.
3. Prevention: includes threat consideration, terrorists acts, acts of war, industrial accidents and incidents, considerations in CW destruction.
4. Protection and decontamination: includes operational, physical, and medical including prophylaxis.
5. Mass Casualty Management: CBR victims in the event of major accidents or incidents and fromwar/combat actions or terrorist attacks to include differentiation, identification, prevention, pre-planning, organization, and interface with military/civil medical authorities.
6. Treatment: CBR casualties from short to long term and follow up.
7. Terrorism: its effect on the civilian and military communities. These topics from across the CBR spectrum include new chemical agents, biological agents, toxins, new treatments, bioterrorism, new detection and decontamination capabilities as apply to CBR casualties, and etc.
8. Training: of First Responders in terrorism, accidents, and incidents when reliance on other government agencies such as military is not feasible.
9. Medical issues include: Pharmaceutical and Medical Equipment Stockpiles; Medical Countermeasures; Commercial and Regulatory issues; Infectious diseases; Public Health Preparedness; Vaccine development and distribution and legal issues
Note: For questions on applicability of proposed papers, the Science Review Committee will help determine either the proper area or they will form a new area.
The below outline provides guidance on the individual session areas as formulated from the proposed topic areas. The CBMTS members may recommend additional areas and/or changes, which will be considered by the CBMTS V Science Advisor and Science Review Committee.
Major Session Areas
1. Medical treatment
Nerve and blistering agents, HCN, irritants, industrial toxic compounds (list 3)
Mid- and long term effects
Means (protection, decontamination, antidotes) and preparation/instruction of first responders; concepts and reality
Mass casualty handling: triage, civilians, children, babies, decontamination on site, hospital
Detection on site
Outlook on novel threats
Oximes: which one for what agent
Agents of concern: biotoxins, pathogenic organisms
Hospital capacities and capabilities
Ranking of threat
Diagnosis, diagnostic kits
Vaccines, antisera and other treatments; state of the art on new ones, on clinical trials
Detection of contamination
Medication, standard treatment
Long term effects: medical, psychological
2. Mass casualty management
Plans for community, industry
Actual state of the art
Lesson from exercises: what worked and what did not
Training of first responders
On hand equipment and procedures
Deliberate distribution through human vectors
Zoonosis (spreading of animal diseases in humans)
4. Pharmaceuticals and Vaccines
5. Detectors and Decontamination
6. Physical and Individual Protection